Rosetta Genomics and the Medical Dilemma of CUP
February 4, 2013
It’s a disease medical science has been battling for years. Cancer continues to claims millions of lives in the United States. But a cutting-edge technology, called MicroRNA Testing, hold promise in our collective effort to identify tumor origins. Tune-in to The Balancing Act as they discuss where this technology is…where it may be going…and how it’s helping patients and doctors defeat this dreaded disease.
Behind the Mystery is a special segment dedicated to revolutionizing the way the health care system works for those suffering from a rare and genetic disorder.
Behind the Mystery takes a closer look at one of the two types of Polycystic Kidney disease. Autosomal Dominant Polycystic Kidney Disease, or ADPKD, is a rare, genetic condition.
Behind the Mystery takes a closer look at Blastic Plasmacytoid Dendritic Cell Neoplasm, a rare disease that is often misdiagnosed and affects at least 500 to 1,000 patients each year in the U.S.